Centiva Capital, LP Abb Vie Inc. Put Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $212,992 - $259,129	1,300 Added 26.0%	6,300 $1.24 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $773,950 - $903,800	5,000 New	5,000 $857,000
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $2.34 Million - $2.63 Million	-17,000 Reduced 70.25%	7,200 $1.12 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $2.27 Million - $2.63 Million	17,000 Added 236.11%	24,200 $3.61 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $556,542 - $692,580	4,200 Added 140.0%	7,200 $970,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $216,915 - $249,810	-1,500 Reduced 33.33%	3,000 $478,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $110,648 - $132,696	-800 Reduced 15.09%	4,500 $727,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.9 Million - $3.32 Million	-21,600 Reduced 80.3%	5,300 $711,000
Q2 2022 Aug 17, 2022	SELL	$137.62 - $174.96 $2.16 Million - $2.75 Million	-15,700 Reduced 36.85%	26,900 $4.12 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $7.11 Million - $8.83 Million	-53,900 Reduced 55.85%	42,600 $6.91 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $9.97 Million - $12.6 Million	92,850 Added 2543.84%	96,500 $13.1 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $388,360 - $440,847	3,650 New	3,650 $394,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $220,941 - $246,141	-2,100 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $828,630 - $912,222	-8,100 Reduced 79.41%	2,100 $227,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $820,998 - $1.11 Million	-10,200 Reduced 50.0%	10,200 $1.09 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $1.82 Million - $2.14 Million	-21,200 Reduced 50.96%	20,400 $1.79 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $1.53 Million - $2.05 Million	-20,900 Reduced 33.44%	41,600 $4.08 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $741,750 - $1.12 Million	-11,500 Reduced 15.54%	62,500 $4.75 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2.82 Million - $3.53 Million	39,100 Added 112.03%	74,000 $6.55 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $1.38 Million - $1.66 Million	-21,900 Reduced 38.56%	34,900 $2.64 Million
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $3.23 Million - $4.12 Million	-49,100 Reduced 46.36%	56,800 $4.13 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $2.68 Million - $3.15 Million	-34,700 Reduced 24.68%	105,900 $8.54 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $7.13 Million - $8.79 Million	91,600 Added 186.94%	140,600 $13 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $4.36 Million - $4.84 Million	49,000 New	49,000 $4.64 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account